F624-2939 Screening compound: 1-(4-fluorophenyl)-N-[2-(morpholin-4-yl)ethyl]-5-(pyridin-3-yl)-1H-pyrazole-3-carboxamide

F624-2939 Screening compound: 1-(4-fluorophenyl)-N-[2-(morpholin-4-yl)ethyl]-5-(pyridin-3-yl)-1H-pyrazole-3-carboxamide
F624-2939 Screening compound: 1-(4-fluorophenyl)-N-[2-(morpholin-4-yl)ethyl]-5-(pyridin-3-yl)-1H-pyrazole-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F624-2939
1-(4-fluorophenyl)-N-[2-(morpholin-4-yl)ethyl]-5-(pyridin-3-yl)-1H-pyrazole-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F624-2939

Molecular Formula

C21H22FN5O2 (C21 H22 FN5 O2)

Compound Name

1-(4-fluorophenyl)-N-[2-(morpholin-4-yl)ethyl]-5-(pyridin-3-yl)-1H-pyrazole-3-carboxamide

IUPAC name

1-(4-fluorophenyl)-N-[2-(morpholin-4-yl)ethyl]-5-(pyridin-3-yl)-1H-pyrazole-3-carboxamide

SMILES

O=C(c(cc1-c2cnccc2)nn1-c(cc1)ccc1F)NCCN1CCOCC1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

395.44

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

1.641

Distribution Coefficient, logD

1.611

Water Solubility, LogSw

-1.48

Polar Surface Area

58.725

Acid Dissociation Constant (pKa)

14.26

Base Dissociation Constant (pKb)

6.26

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

28.60

F624-2939 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Cardiovascular Library (22201 compounds)

GPCR Targeted Library (31838 compounds)

Nucleic Acid Ligands (8311 compounds)

Proline Kinase Library (2105 compounds)

SH2 Library (10483 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cardiovascular
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system
  • Cancer
  • Digestive system
  • Nervous system
  • Male
  • Female
  • Endocrine
  • Cancer
  • Endocrine
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands
  • PPI modulators

References: we are preparing a list of scientific research reports with F624-2939 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F624-2939?
Check Price and Availability of F624-2939, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F624-2939 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F624-2939
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F624-2939
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F624-2939 available by request